National trends and disparities inmammography among commercially insuredwomen, 2001-2010

Journal of Public Health Management and Practice

Volumn 21, Issue 5, 2015, Pages 426-432

  Wharam, J Frank ^a   Landon, Bruce E ^b   Xu, Xin ^a   Fang, Zhang ^a   Ross Degnan, Dennis ^a  

^a HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Cancer screening; Health care disparities; Mammography; Vulnerable populations; Women's health

Indexed keywords

ADULT; BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; HEALTH CARE DISPARITY; HUMAN; INSURANCE; LONGITUDINAL STUDY; MAMMOGRAPHY; MIDDLE AGED; SOCIOECONOMICS; UNITED STATES; UTILIZATION;

ADULT; BREAST NEOPLASMS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; LONGITUDINAL STUDIES; MAMMOGRAPHY; MIDDLE AGED; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84942913393     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/PHH.0000000000000101     Document Type: Article

References (45)

1. 2006-2010 Top Ten Cancers. National Program ofCancer Registries. http://apps.nccd.cdc.gov/uscs/toptencancers.aspx. Published 2014. Accessed 11 February, 2014.
2. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screeningwithmammography. Randomised trial from the Breast Cancer ScreeningWorking Group of the Swedish National Board of Health andWelfare. Lancet.1985;1(8433):829-832.
3. Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990;335(8684):241-246.
4. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality frombreast cancer: the Malmo mammographic screening trial. BMJ. 1988;297(6654):943-948.
5. Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy andmammography onU.S.mortality from1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006;2006(36):112-121.
6. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality frombreast cancer.NEngl J Med. 2005;353(17):1784-1792.
7. Christensen LH, Engholm G, Cortes R, et al. Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden. Eur J Cancer. 2006;42(16):2773-2780.
8. Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non-Adherence to adjuvant hormonal therapy are associated with increasedmortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529-537.
9. Laara E, Day NE, Hakama M. Trends in mortality fromcervical cancer in theNordic countries: associationwith organised screening programmes. Lancet. 1987;1(8544):1247-1249.
10. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113(3):214-226.
11. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6: CD001877.
12. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer. 2010;116(20):4872-4881.
13. Chagpar AB, Polk HC Jr., McMasters KM. Racial trends in mammography rates: a population-based study. Surgery. 2008;144(3):467-472.
14. Zhou J, Enewold L, Peoples GE, et al. Trends in cancer screening among Hispanic and white non-Hispanic women, 2000-2005. J Womens Health (Larchmt). 2010;19(12):2167-2174.
15. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev. 2009;18(1):121-131.
16. Chagpar AB, McMasters KM. Trends in mammography and clinical breast examination: a population-based study. J Surg Res. 2007;140(2):214-219.
17. Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices amongwomenin rural and urban areas of the United States. J Public HealthManag Pract. 2009;15(3):200-209.
18. Kim J, Jang SN. Socioeconomic disparities in breast cancer screening among US women: trends from2000 to 2005. J Prev Med Public Health. 2008;41(3):186-194.
19. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011;117(10):2209-2218.
20. Miranda PY, Tarraf W, Gonzalez P, Johnson-Jennings M, Gonzalez HM. Breast cancer screening trends in the United States and ethnicity. Cancer Epidemiol Biomarkers Prev. 2012; 21(2):351-357.
21. RyersonAB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in U.S. mammography use from 2000-2006: a population-based analysis. Prev Med. 2008;47(5):477-482.
22. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern. Med. 2009;151(10):716-726, W-236.
23. Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009;7(10):1060-1096.
24. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003;53(3):141-169.
25. American College of Obstetricians-Gynecologists. Practice bulletin no. 122: breast cancer screening. Obstet Gynecol. 2011;118(2 pt 1):372-382.
26. American Medical Association. AMA adopts new policies at annual meeting. http://www.ama-Assn.org/ama/pub/news/news/2012-06-19-Ama-Adopts-new-policies.page. Published 2012. Accessed November 25, 2012.
27. American College of Radiology. ACR Appropriateness Criteria Rbreast cancer screening. 2012:5. http://www.acr .org/?/media/ACR/Documents/AppCriteria/Diagnostic/BreastCancerScreening.pdf. Accessed November 25, 2012.
28. U.S. Department ofHealth & Human Services. Healthy People 2010. Conference ed. Washington, DC: U.S. Department of Health & Human Services; 2000.
29. Healthy People 2020. http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx. Accessed December 10, 2013.
30. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures-the public health disparities geocoding project. Am J Public Health. 2003;93(10):1655-1671.
31. United States Census Bureau. Geographical Areas Reference Manual.Washington,DC: United States Census Bureau; 1994.
32. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351.
33. Lerman PM. Fitting segmented regression models by grid search. Appl Stat. 1980;29:77-84.
34. Edgington ES, Onghena P. Randomization Tests. 4th ed. Boca Raton, FL: Chapman & Hall/CRC; 2007.
35. National Breast and Cervical Cancer Early Detection Program. http://www.cdc.gov/Cancer/nbccedp/pdf/NBCC EDP-FactSheet.pdf. Published 2013. Accessed May 7, 2014.
36. Mammograms Harder to Get, Report Finds. http://www .nytimes.com/2004/06/11/us/mammograms-harder-to-get-report-finds.html. Published 2004. Accessed August 21, 2013.
37. Joy JE, Penhoet EE, Petitti DB; National Cancer Policy Board (U.S.), Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer, National Research Council (US), Policy and Global Affairs, National Research Council (US), Board on Science Technology and Economic Policy. SavingWomen's Lives : Strategies for Improving Breast Cancer Detection and Diagnosis.Washington, DC: TheNational Academies Press; 2005.
38. HEDIS 2013. http://www.ncqa.org/HEDISQuality Measurement/HEDISMeasures/HEDIS2013.aspx. Accessed August 20, 2013.
39. Breast cancer screening. http://www.hrsa.gov/quality/toolbox/508pdfs/breastcancerscreening.pdf. Accessed August 20, 2013.
40. Accountable Care Organization 2013. Program analysis: quality performance standards narrative measure specifications. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/ACONarrativeMeasures-Specs.pdf. Published 2013. Accessed August 20, 2013.
41. U.S. Department ofHealth & Human Services. Healthy People 2010 : Understanding and Improving Health. Rev ed. Boston, MA: Jones and Bartlett Publishers; 2001.
42. Miller AB,Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.
43. Miller JW, King JB, Ryerson AB, Eheman CR, White MC. Mammography use from 2000 to 2006: state-level trends with corresponding breast cancer incidence rates. AJR Am J Roentgenol. 2009;192(2):352-360.
44. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 2013;119(14):2518-2523.
45. Njai R, Siegel PZ, Miller JW, Liao Y. Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995-2006. Prev Chronic Dis. 2011;8(3):A59.